moelis & co. - MC
MC
Close Chg Chg %
71.71 1.49 2.08%
Closed Market
73.20
+1.49 (2.08%)
Volume: 1.43M
Last Updated:
Feb 6, 2026, 3:59 PM EDT
Company Overview: moelis & co. - MC
MC Key Data
| Open $72.35 | Day Range 71.88 - 74.66 |
| 52 Week Range 47.01 - 81.40 | Market Cap $5.25B |
| Shares Outstanding 74.00M | Public Float 73.24M |
| Beta 1.87 | Rev. Per Employee N/A |
| P/E Ratio 24.38 | EPS $3.11 |
| Yield 362.72% | Dividend $0.65 |
| EX-DIVIDEND DATE Nov 10, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 919.26K |
MC Performance
| 1 Week | 0.01% | ||
| 1 Month | -3.89% | ||
| 3 Months | 12.16% | ||
| 1 Year | -9.04% | ||
| 5 Years | 38.62% |
MC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 80.00 | |
| Number of Ratings | 11 | Current Quarters Estimate | 0.715 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 3.475 | |
| Last Quarter’s Earnings | 1.13 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.99 | Next Fiscal Year Estimate | 4.269 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 11 | 11 | 11 |
| Mean Estimate | 0.71 | 0.74 | 3.48 | 4.27 |
| High Estimates | 0.96 | 0.83 | 3.85 | 4.98 |
| Low Estimate | 0.48 | 0.62 | 3.25 | 3.70 |
| Coefficient of Variance | 22.98 | 10.48 | 5.93 | 9.75 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 7 | 7 | 4 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Hold | Hold | Overweight |
SEC Filings for Moelis & Co. - MC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Moelis & Co. - MC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 63,517 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Eric Cantor Vice Chairman, MD; Director | 25,855 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Osamu R. Watanabe General Counsel, Secretary | 12,132 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 897,768.00 |
| Feb 24, 2025 | Osamu R. Watanabe General Counsel, Secretary | 12,135 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 209,235 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 15,483,390.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 218,947 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 16,202,078.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 218,948 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 54,794 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 4,054,756.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 63,516 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 4,700,184.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 28,591 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 197,602 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 14,622,548.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 207,008 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 15,318,592.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 207,009 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth L. Shropshire Director | 6,940 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.3 per share | 501,762.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 4,358 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 22,832 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 1,689,568.00 |